The ability to infect macrophages is a common characteristic shared among many mycobacterial species. Mycobacterium avium, Mycobacterium tuberculosis, and Mycobacterium kansasii enter macrophages, using the complement receptors CR1, CR3, CR4, and the mannose receptor. To identify M. avium genes and host cell pathways involved in the bacterial uptake by macrophages, we screened a M. avium transposon mutant library for the inability to enter macrophages. Uptake-impaired clones were selected. Sequence of six M. avium clones identified one gene involved in glycopeptidolipid biosynthesis, one gene encoding the conserved membrane protein homologue to the M. avium subsp. paratuberculosis MAP2446c gene and four others belonging to the same region of the chromosome. Analysis of the chromosome region revealed a pathogenicity island inserted between two tRNA sequences with 58% of G؉C content versus 69% in the M. avium genome. The region is unique for M. avium and is not present in M. tuberculosis or M. paratuberculosis. Although the mutants did not differ from the WT bacterium regarding the binding to macrophage cell membrane, analysis of macrophage proteins after 1 h infection revealed a deficiency in the mutant to phosphorylate certain proteins on uptake. To understand M. avium interaction with two evolutionarily distinct hosts, the mutants were evaluated for Acanthamoeba castellanii invasion. The defect in the ability of the mutants to invade both cells was highly similar, suggesting that M. avium might have evolved mechanisms that are used to enter amoebas and human macrophages. uptake M ycobacterium avium complex is an intracellular pathogen that can infect a variety of host cells (1-4). M. avium, like the majority of pathogenic mycobacteria, infects and replicates within macrophages (5, 6), which are the phagocytic cells where M. avium establishes a long-term infection (7).A number of studies in vitro have determined that M. avium, in a manner similar to Mycobacterium tuberculosis, is taken up by macrophages using the complement receptors CR3, CR4, and CR1 (8-10), and/or the mannose receptor (8, 11). M. tuberculosis has been found to bind to the CD11b chain of the -integrin of the CR3 and CR4 receptors, which happened without participation of the serum complement proteins (10). Other studies demonstrated that the mannose capped lipoarabinomannan antigen of virulent M. tuberculosis cell wall is capable to recognize and bind to the mannose receptors on the macrophage membrane (11).It has been hypothesized that virulent mycobacteria bind to many receptors because pathogenic mycobacteria would use several different receptors on the macrophage membrane to be internalized, as a strategy to guarantee phagocytosis, even when a sitespecific macrophage would not contain one or more membrane receptors. In addition, this property would address the possibility that mycobacteria may not express all of the ligands during all phases of infection. Most mycobacteria evolved to survive inside phagocytic cells, although they can enter ...